Bishop Hans Edgar — SEC insider filings
SEC reporting owner CIK 1480212. 39 insider filings on record with FilingPulse; latest filed 2026-10-06.
Transaction summary — filings shown
Covers all 39 filings on record, filed 2021-02-05 to 2026-10-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 49.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | Director | 28 | — | — | 31 |
| Lyell Immunopharma, Inc. (LYEL) | Director | 7 | — | — | 10 |
| AGILENT TECHNOLOGIES, INC. (A) | Director | 4 | — | — | 8 |
Insider filings — Bishop Hans Edgar
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-06 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 8,680 @ $0 | EDGAR |
| 2026-07-07 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 6,297 @ $0 | EDGAR |
| 2026-06-05 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2026-04-08 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 7,763 @ $0 | EDGAR |
| 2026-01-06 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 6,157 @ $0 | EDGAR |
| 2025-10-07 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 5,628 @ $0 | EDGAR |
| 2025-07-08 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 7,842 @ $0 | EDGAR |
| 2025-06-09 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 16,339 @ $0 | EDGAR |
| 2025-01-07 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 14,285 @ $0 | EDGAR |
| 2024-10-09 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 5,938 @ $0 | EDGAR |
| 2024-07-15 | 4/A | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-07-08 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 4,911 @ $0 | EDGAR |
| 2024-06-17 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 54,278 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 2,774 @ $0 | EDGAR |
| 2024-03-19 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 1,678 @ $147.48 · Grant/award (A): 750 @ $147.48 | EDGAR |
| 2024-01-08 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 4,901 @ $0 | EDGAR |
| 2023-10-06 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 6,925 @ $0 | EDGAR |
| 2023-09-08 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2023-07-06 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 4,152 @ $0 | EDGAR |
| 2023-06-20 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2023-04-06 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 7,716 @ $0 | EDGAR |
| 2023-03-20 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 1,658 @ $136.82 · Grant/award (A): 741 @ $136.82 | EDGAR |
| 2023-01-06 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 6,702 @ $0 | EDGAR |
| 2022-10-06 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 4,012 @ $0 | EDGAR |
| 2022-09-09 | 4 | Lyell Immunopharma, Inc. (LYEL) | Option exercise (M): 145,380 @ $0.10 · Option exercise (M): 145,380 (derivative) @ $0 | EDGAR |
| 2022-07-07 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 3,328 @ $0 | EDGAR |
| 2022-06-10 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2022-06-08 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2022-04-06 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 2,880 @ $0 | EDGAR |
| 2022-03-21 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 1,785 @ $136.82 · Grant/award (A): 797 @ $136.82 | EDGAR |
| 2022-02-25 | 4 | Lyell Immunopharma, Inc. (LYEL) | Option exercise (M): 993,428 @ $0.10 · Option exercise (M): 993,428 (derivative) @ $0 | EDGAR |
| 2021-06-23 | 4 | Lyell Immunopharma, Inc. (LYEL) | Conversion (C): 546,806 · Conversion (C): 546,806 (derivative) @ $0 | EDGAR |
| 2021-03-22 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 1,850 @ $121.59 · Grant/award (A): 822 @ $121.59 | EDGAR |
| 2021-02-18 | 4/A | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 23,591 (derivative) @ $0 | EDGAR |
| 2021-02-10 | 4 | Sana Biotechnology, Inc. (SANA) | Conversion (C): 2,031,250 · Conversion (C): 1,075,000 (derivative) @ $0 · Conversion (C): 800,000 (derivative) @ $0 · Conversion (C): 156,250 (derivative) @ $0 | EDGAR |
| 2021-02-05 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1480212 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs